Oral Selective Estrogen Receptor Degrader for Advanced Breast Cancer

J Clin Oncol. 2024 Jan 10;42(2):240. doi: 10.1200/JCO.23.01656. Epub 2023 Oct 30.

Authors

Yutaro Yoshitomi¹, Akihiko Shimomura¹, Chikako Shimizu¹

Affiliation

¹ Yutaro Yoshitomi,MD; Akihiko Shimomura, MD, PhD; and Chikako Shimizu, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.

PMID: 37903313
DOI: 10.1200/JCO.23.01656

No abstract available

Publication types

Letter

MeSH terms

Breast Neoplasms* / drug therapy
Estrogen Receptor alpha
Female
Humans
Selective Estrogen Receptor Modulators / therapeutic use

Substances

Selective Estrogen Receptor Modulators
Estrogen Receptor alpha